Evogene Schedules Fourth Quarter 2024 Financial Results Release
21 February 2025, Rehovot: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and
Read More21 February 2025, Rehovot: Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and
Read MoreFourth Quarter 2024 Highlights Full-Year 2024 Highlights Full-Year 2025 Outlook2 06 February 2025, US: FMC Corporation (NYSE:FMC) today reported fourth quarter 2024
Read MoreThe following is an extract from the press release “CNH Industrial N.V. Reports Fourth Quarter and Full Year 2024 Results”. The
Read More